What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to higher education
- Print number 8276a
- Amend and recommit to higher education
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Restricts retail sale of dextromethorphan, commonly known as DXM, to behind the pharmacy counter or under manager control
In Senate Committee · Higher Education · Sponsor Suzi Oppenheimer
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:A8276A
Title of bill
An act to amend the education law, in relation to restricting access to dextromethorphan, commonly known as "dxm"
Purpose
To require that any retail establishment that sells any product or products containing as the only active ingredient dextromethorphan to limit access to such products to those 18 years of age or younger in a manner designed to prevent the misuse or abuse of such products.
Summary of provisions
Section 1 Amends the education law by adding a new section 6811-c to restrict access to retail sale of dexotromethor- phan, commonly known as "DXM"
Justification
The abuse of DXM-now being called the next crystal meth- is increasing among teens. Since the 1950s DXM has been used primarily as a safe over-the-counter medicine. However in recent years an increas- ing number of teens have been abusing the substance because of its easy accessibility. As an OTC drug there are no restrictions as to who can purchase medicine containing DXM or how much can be purchased. A signif- icant number of teens are under the misconception that since it is an OTC medicine, it is therefore harmless. The reverse is true. Abuse of DXM has been found to cause serious side-effects and even death. The effects vary with the amount taken and include confusion, dizziness, double or blurred vision, slurred speech, vomiting, rapid heart beat, numbness of fingers and toes, and disorientation. Extremely high doses of DXM can induce a hallucinatory state that can lead to accidental deaths. Teens abuse DXM to experience the visual hallucinations and sensations similar to other dissociative anesthetics like PCP and Keta- mine. The limitations this bill imposes will greatly reduce its poten- tial dangers to our teen population.
Legislative history
New Bill.
Fiscal implications
None
Effective date
This act shall take effect immediately; provided: however, that the rules and regulations necessary to implement section one of this act shall be promulgated and take effect on or before the one hundred eightieth day after this act shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.